tailieunhanh - Malignancy in giant cell tumor of bone: Analysis of an open-label phase 2 study of denosumab

Giant cell tumor of bone (GCTB) is a rare osteoclastogenic stromal tumor. GCTB can rarely undergo malignant transformation. This post hoc analysis evaluated and classified malignancies in patients with GCTB who received denosumab. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN